Cargando…

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer

A plethora of previous studies have been focused on the role of indoleamine 2,3-dioxygenase 1 (IDO1) in cancer immunity; however, the alternative way of targeting tryptophan 2,3-dioxygenase (TDO2) in cancer immunotherapy has been largely ignored. In particular, the specific role of TDO2 in breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qiang, Zhai, Jie, Kong, Xiangyi, Wang, Xiangyu, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178007/ https://www.ncbi.nlm.nih.gov/pubmed/32346606 http://dx.doi.org/10.1016/j.omto.2020.03.013

Ejemplares similares

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
por: Liu, Qiang, et al.
Publicado: (2021)

A Systematic Study on Zinc-Related Metabolism in Breast Cancer
por: Qu, Zheng, et al.
Publicado: (2023)

Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study
por: Ai, Bolun, et al.
Publicado: (2020)

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020)

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2020)

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
por: Qi, Yihang, et al.
Publicado: (2021)

Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2021)

NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis
por: Liu, Qiang, et al.
Publicado: (2021)

Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix
por: Gao, Peng, et al.
Publicado: (2020)

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
por: Ai, Bolun, et al.
Publicado: (2019)

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data
por: Liu, Qiang, et al.
Publicado: (2020)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?
por: Wang, Jing, et al.
Publicado: (2017)

Expression signatures and roles of microRNAs in inflammatory breast cancer
por: Qi, Yihang, et al.
Publicado: (2019)

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Retraction Note: LncMAPK6 drives MAPK6 expressionand liver TIC self-renewal
por: Huang, Guanqun, et al.
Publicado: (2022)

Subsequent risk of suicide among 9,300,812 cancer survivors in US: A population-based cohort study covering 40 years of data
por: Liu, Qiang, et al.
Publicado: (2022)

Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs
por: Cheng, Ran, et al.
Publicado: (2020)

The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
por: Dong, Hao, et al.
Publicado: (2023)

Comprehensive behavioral analysis of tryptophan 2,3‐dioxygenase (Tdo2) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2018)

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
por: Li, Yuan, et al.
Publicado: (2021)

TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
por: Pham, Quoc Thang, et al.
Publicado: (2021)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
por: Cheng, Ran, et al.
Publicado: (2020)

PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism
por: Dong, Hao, et al.
Publicado: (2022)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
por: Zhu, Mengliu, et al.
Publicado: (2022)

Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1–2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study
por: WANG, Xiangyu, et al.
Publicado: (2020)

Prognostic Value and Clinical Significance of LIPH in Breast Cancer
por: Gao, Peng, et al.
Publicado: (2021)

The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

Controlling Nutritional Status (CONUT) as a Novel Postoperative Prognostic Marker in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Pharmacological validation of TDO as a target for Parkinson’s disease
por: Perez‐Pardo, Paula, et al.
Publicado: (2021)

Primary Giant Cell Tumor of the Breast With Pulmonary Metastasis: A Case Report and Review of the Literature
por: Zhang, Wenxiang, et al.
Publicado: (2021)

TDO2(+) myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma
por: Hu, Simeng, et al.
Publicado: (2022)

Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies
por: Kong, Xiangyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cpsl9a4lngnuu0qrhni0ahh2nd